Effects of Sirolimus on Asymptomatic ApoE4 Carriers

NCT07728175 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Genetic Predisposition to Disease
Healthy Volunteer
APOE-4 Positive

Interventions

DRUG: Sirolimus (rapamycin)
DRUG: Placebo

Sponsor

University of Missouri-Columbia